Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists.

× No keyword cloud information.

6 in total

1. Infections in patients with rheumatoid arthritis treated with biologic agents.

Authors: Joachim Listing; Anja Strangfeld; Sonja Kary; Rolf Rau; Ulrich von Hinueber; Maria Stoyanova-Scholz; Erika Gromnica-Ihle; Christian Antoni; Peter Herzer; Jörn Kekow; Matthias Schneider; Angela Zink
Journal: Arthritis Rheum Date: 2005-11

Review 2. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors: Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal: JAMA Date: 2006-05-17 Impact factor: 56.272

3. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.

Authors: Frederick Wolfe; Liron Caplan; Kaleb Michaud
Journal: Arthritis Rheum Date: 2006-02

4. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Authors: W G Dixon; K Watson; M Lunt; K L Hyrich; A J Silman; D P M Symmons
Journal: Arthritis Rheum Date: 2006-08

5. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.

Authors: Jeffrey R Curtis; Nivedita Patkar; Aiyuan Xie; Carolyn Martin; Jeroan J Allison; Michael Saag; Deborah Shatin; Kenneth G Saag
Journal: Arthritis Rheum Date: 2007-04

6. Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

Authors: R S Wallis; M S Broder; J Y Wong; M E Hanson; D O Beenhouwer
Journal: Clin Infect Dis Date: 2004-04-15 Impact factor: 9.079

6 in total

21 in total

1. Improvements in cystic fibrosis lung disease and airway inflammation associated with etanercept therapy for rheumatoid arthritis: a case report.

Authors: S Visser; M Martin; D J Serisier
Journal: Lung Date: 2012-06-04 Impact factor: 2.584

2. Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.

Authors: Yoon-Kyoung Sung; Soo-Kyung Cho; Dam Kim; Soyoung Won; Chan-Bum Choi; So-Young Bang; Seung-Jae Hong; Hyoun Ah Kim; Eun-Mi Koh; Hye-Soon Lee; Chang-Hee Suh; Dae-Hyun Yoo; Sang-Cheol Bae
Journal: Rheumatol Int Date: 2017-02-18 Impact factor: 2.631

3. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.

Authors: Jeffrey R Curtis; Archana Jain; Johan Askling; S Louis Bridges; Loreto Carmona; William Dixon; Axel Finckh; Kimme Hyrich; Jeffrey D Greenberg; Joel Kremer; Joachim Listing; Kaleb Michaud; Ted Mikuls; Nancy Shadick; Daniel H Solomon; Michael E Weinblatt; Fred Wolfe; Angela Zink
Journal: Semin Arthritis Rheum Date: 2010-08 Impact factor: 5.532

Review 4. Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature.

Authors: Archana Jain; Jasvinder A Singh
Journal: Immunotherapy Date: 2013-03 Impact factor: 4.196

5. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.

Authors: Candace H Feldman; Francisco M Marty; Wolfgang C Winkelmayer; Hongshu Guan; Jessica M Franklin; Daniel H Solomon; Karen H Costenbader; Seoyoung C Kim
Journal: Arthritis Rheumatol Date: 2017-02 Impact factor: 10.995

6. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.

Authors: Carlos G Grijalva; Lang Chen; Elizabeth Delzell; John W Baddley; Timothy Beukelman; Kevin L Winthrop; Marie R Griffin; Lisa J Herrinton; Liyan Liu; Rita Ouellet-Hellstrom; Nivedita M Patkar; Daniel H Solomon; James D Lewis; Fenglong Xie; Kenneth G Saag; Jeffrey R Curtis
Journal: JAMA Date: 2011-11-06 Impact factor: 56.272

7. Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.

Authors: Huifeng Yun; Fenglong Xie; Elizabeth Delzell; Lang Chen; Emily B Levitan; James D Lewis; Kenneth G Saag; Timothy Beukelman; Kevin Winthrop; John W Baddley; Jeffrey R Curtis
Journal: Ann Rheum Dis Date: 2014-03-07 Impact factor: 19.103

Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists.